| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a medicament for patients with an extracorporeal blood circuit, for example, patients undergoing hemodialysis, which can effectively and safely prevent formation of blood clotting without increasing a risk of hemorrhage. <P>SOLUTION: The medicament prevents formation of blood clotting in patients with an extracorporeal blood circuit, and is suitable for intravenous administration and anticoagulant coating; the medicament includes a synthetic oligosaccharide containing uronic acid, glucopyranoside, etc., as its skeleton, and is a selective inhibitor of factor Xa, acting via antithrombin III. <P>COPYRIGHT: (C)2010,JPO&INPIT |
